Paroxysmal Nocturnal Hemoglobinuria (PNH) Latest Advances

Find the Latest Research About Paroxysmal Nocturnal Hemoglobinuria (PNH)

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4895 publications

Advancing treatment goals for paroxysmal nocturnal hemoglobinuria to align with quality of life improvements in the era of anti-complement therapy

Advancing treatment goals for paroxysmal nocturnal hemoglobinuria to align with quality of life improvements in the era of anti-complement therapy

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: January 12, 2026

Cost per responder analysis of iptacopan versus eculizumab and ravulizumab in treatment of paroxysmal nocturnal hemoglobinuria: implications for decision-making.

Cost per responder analysis of iptacopan versus eculizumab and ravulizumab in treatment of paroxysmal nocturnal hemoglobinuria: implications for decision-making.

Journal: Journal of medical economics
Published: January 10, 2026

Discovery of (3R,4R)-15: An Advanced Factor B Inhibitor Entering Phase 3 for Complement-Mediated Diseases.

Discovery of (3R,4R)-15: An Advanced Factor B Inhibitor Entering Phase 3 for Complement-Mediated Diseases.

Journal: Journal of medicinal chemistry
Published: January 09, 2026

Targeting complement in atypical hemolytic and uremic syndrome: development and current status of eculizumab and ravulizumab

Targeting complement in atypical hemolytic and uremic syndrome: development and current status of eculizumab and ravulizumab

Journal: Nephrologie & therapeutique
Published: January 05, 2026

Real-world clinical outcomes and treatment response in complement inhibitor experienced and naïve PNH patients prescribed pegcetacoplan in Europe and Canada.

Real-world clinical outcomes and treatment response in complement inhibitor experienced and naïve PNH patients prescribed pegcetacoplan in Europe and Canada.

Journal: Hematology (Amsterdam, Netherlands)
Published: January 02, 2026

The night has many faces: When schistocytes step out of line

The night has many faces: When schistocytes step out of line

Journal: Praxis
Published: December 11, 2025

Whole genome sequencing confirms reactivation of Tuberculosis five years after initial infection despite adequate preventative therapy in a patient with profound immunosuppression.

Whole genome sequencing confirms reactivation of Tuberculosis five years after initial infection despite adequate preventative therapy in a patient with profound immunosuppression.

Journal: QJM : monthly journal of the Association of Physicians
Published: December 10, 2025

Molecular approach to cytopenia and bone marrow failure.

Molecular approach to cytopenia and bone marrow failure.

Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025

The varieties of therapeutic experience: navigating treatment options for patients with PNH.

The varieties of therapeutic experience: navigating treatment options for patients with PNH.

Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025

Therapeutic Antibodies in Hematology: Advances in Malignant and Non-Malignant Disorders.

Therapeutic Antibodies in Hematology: Advances in Malignant and Non-Malignant Disorders.

Journal: Cells
Published: December 02, 2025

Paroxysmal Nocturnal Hemoglobinuria-Driven Hepatic Vein Thrombosis: A Case of Budd-Chiari Syndrome in Disguise.

Paroxysmal Nocturnal Hemoglobinuria-Driven Hepatic Vein Thrombosis: A Case of Budd-Chiari Syndrome in Disguise.

Journal: Cureus
Published: November 23, 2025

Pathophysiology of Primary Budd-Chiari Syndrome: A Narrative Review.

Pathophysiology of Primary Budd-Chiari Syndrome: A Narrative Review.

Journal: Cureus
Published: November 10, 2025
Showing 1-12 of 4,895

Last Updated: 02/24/2026